The Spatiotemporal Heterogeneity of Tumor-Associated Stromal Cells: Reprogramming Plasticity to Unlock Precision Cancer Immunotherapy
Cancer Communications · 2026
DOI: 10.34133/cancomm.0002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Communications, 2026. Verfasst von Yingying Lv und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P. R. China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Immunotherapy, Stromal Cells, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 289 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Tumor-associated stromal cells (TASCs) are key architects of the tumor microenvironment (TME), playing a vital role in tumor development, metastasis, and therapeutic response. Their spatiotemporal heterogeneity, characterized by dynamic phenotypic plasticity, diverse cellular subtypes, and distinct spatial distributions, offers profound insights into tumor behavior and paves the way for innovative therapy development. In particular, stromal–immune interactions reveal the powerful capacity of TASCs to shape the immune landscape, highlighting their potential as targets in immunotherapy. Despite growing evidence in functional diversity, precise mechanisms underlying the temporal evolution and spatial organization of TASCs remain elusive, impeding clinical translation. This review delved into the molecular signatures and functional states of TASCs, emphasizing their roles in tumor dynamics and therapeutic resistance. We also discussed innovative strategies targeting the plasticity of TASCs to reverse immune evasion and potentiate immune-mediated tumor eradication. Future studies should prioritize identifying spatially resolved and mechanically defined biomarkers with multi-omics and machine learning approaches, enabling a comprehensive understanding of TASCs to bridge the gap from bench to bedside.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P. R. China.
- Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P. R. China.
- Department of Pediatrics, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P. R. China.
- Division of Pulmonology, Department of Pediatrics, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P. R. China.
- Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, P. R. China.
- Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P. R. China.
ORCID-Profile: Zaoqu Liu
Zitieren
APA
Lv, Y., Duan, T., Song, J., Liu, S., Zhou, Z., Ba, Y., Weng, S., Zuo, A., Xu, H., Luo, P., Cheng, Q., Zhang, C., Ning, J., Chen, Y., Zhang, Y., Liu, Z., & Han, X. (2026). The Spatiotemporal Heterogeneity of Tumor-Associated Stromal Cells: Reprogramming Plasticity to Unlock Precision Cancer Immunotherapy. Cancer Communications. https://doi.org/10.34133/cancomm.0002
Vancouver
Lv Y, Duan T, Song J, Liu S, Zhou Z, Ba Y, et al. The Spatiotemporal Heterogeneity of Tumor-Associated Stromal Cells: Reprogramming Plasticity to Unlock Precision Cancer Immunotherapy. Cancer Communications. 2026. doi:10.34133/cancomm.0002
BibTeX
@article{Lv2026,
author = {Lv, Yingying and Duan, Tingfei and Song, Jinling and Liu, Shutong and Zhou, Zhaokai and Ba, Yuhao and Weng, Siyuan and Zuo, Anning and Xu, Hui and Luo, Peng and Cheng, Quan and Zhang, Chuhan and Ning, Jingyuan and Chen, Yukang and Zhang, Yuyuan and Liu, Zaoqu and Han, Xinwei},
title = {The Spatiotemporal Heterogeneity of Tumor-Associated Stromal Cells: Reprogramming Plasticity to Unlock Precision Cancer Immunotherapy},
journal = {Cancer Communications},
year = {2026},
doi = {10.34133/cancomm.0002}
}
EUVIMED